vs
NORTHPOINTE BANCSHARES INC（NPB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NORTHPOINTE BANCSHARES INC的1.1倍（$69.8M vs $63.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 34.9%，领先349.1%）
Northpointe Bancshares Inc是一家美国银行控股公司，通过旗下全资银行子公司开展业务，提供各类零售及商业银行服务，涵盖存款账户、住房抵押贷款、小微企业信贷、财富管理等，主要服务美国本土区域社区客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NPB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$63.4M
净利率更高
RIGL
高出349.1%
34.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.4M | $69.8M |
| 净利润 | $22.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 34.9% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.62 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPBRIGL
| Q1 26 | $63.4M | — | ||
| Q4 25 | $43.5M | $69.8M | ||
| Q3 25 | $40.3M | $69.5M | ||
| Q2 25 | $36.5M | $101.7M | ||
| Q1 25 | $30.4M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | — | $36.8M |
净利润NPBRIGL
| Q1 26 | $22.2M | — | ||
| Q4 25 | $23.6M | $268.1M | ||
| Q3 25 | $22.2M | $27.9M | ||
| Q2 25 | $20.3M | $59.6M | ||
| Q1 25 | $17.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-1.0M |
毛利率NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 73.5% | 33.2% | ||
| Q3 25 | 72.3% | 40.9% | ||
| Q2 25 | 73.0% | 60.1% | ||
| Q1 25 | 74.4% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% |
净利率NPBRIGL
| Q1 26 | 34.9% | — | ||
| Q4 25 | 54.4% | 384.0% | ||
| Q3 25 | 55.0% | 40.2% | ||
| Q2 25 | 55.7% | 58.6% | ||
| Q1 25 | 56.8% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | -2.8% |
每股收益（稀释后）NPBRIGL
| Q1 26 | $0.62 | — | ||
| Q4 25 | $0.54 | $14.11 | ||
| Q3 25 | $0.57 | $1.46 | ||
| Q2 25 | $0.51 | $3.28 | ||
| Q1 25 | $0.49 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $487.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $590.0M | $391.5M |
| 总资产 | $7.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NPBRIGL
| Q1 26 | $487.6M | — | ||
| Q4 25 | $496.5M | $155.0M | ||
| Q3 25 | $419.2M | $137.1M | ||
| Q2 25 | $415.7M | $108.4M | ||
| Q1 25 | $321.5M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益NPBRIGL
| Q1 26 | $590.0M | — | ||
| Q4 25 | $569.0M | $391.5M | ||
| Q3 25 | $623.5M | $117.6M | ||
| Q2 25 | $604.3M | $81.9M | ||
| Q1 25 | $586.5M | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M |
总资产NPBRIGL
| Q1 26 | $7.4B | — | ||
| Q4 25 | $7.0B | $513.6M | ||
| Q3 25 | $6.8B | $242.5M | ||
| Q2 25 | $6.4B | $206.7M | ||
| Q1 25 | $5.9B | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M |
负债/权益比NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $-28.3M | $22.0M | ||
| Q3 25 | $90.4M | $24.0M | ||
| Q2 25 | $-72.3M | $30.5M | ||
| Q1 25 | $54.4M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K |
自由现金流NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $-28.8M | — | ||
| Q3 25 | $89.6M | — | ||
| Q2 25 | $-73.4M | — | ||
| Q1 25 | $54.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | -66.1% | — | ||
| Q3 25 | 222.3% | — | ||
| Q2 25 | -201.1% | — | ||
| Q1 25 | 178.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率NPBRIGL
| Q1 26 | — | — | ||
| Q4 25 | -1.20× | 0.08× | ||
| Q3 25 | 4.08× | 0.86× | ||
| Q2 25 | -3.55× | 0.51× | ||
| Q1 25 | 3.16× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NPB
| Net Interest Income | $41.3M | 65% |
| Noninterest Income | $22.1M | 35% |
RIGL
暂无分部数据
